Posts Tagged ‘Dr. Paul Knoepfler’

Trying to get it right: a blog carnival about Right to Try

Author: Stacey Johnson, 08/29/17

The crux of Right to Try legislation, enacted by 37 U.S. states so far, is the premise that terminally ill patients should have access to experimental therapies, even if they haven’t been approved by the Food and Drug Administration yet. It sounds straight-forward right? My body, my risk, my decision. The U.S. already has measures…Read more

Weighing in on a controversial topic

Author: Stacey Johnson, 08/23/17

We are less than one week away from Signals’ second blog carnival! Last month I promised to reveal the topic and the participants. I also hinted that this year’s topic might strike some readers as controversial. Given that a few invited bloggers declined to participate, I’d have to say that’s the case. So although our…Read more

Right Turn: The why and how of communicating science to media

Author: Stacey Johnson, 08/04/17

Engaging with the media is not for the faint of heart, but speaking on behalf of the entire world, we need you to step up scientists! Your research is important and valuable, and you may (I chose that word deliberately) be the best person to communicate it. So, while the prospect of doing a media…Read more

Right Turn: My question to Paul Knoepfler: Do you ever sleep?

Author: Stacey Johnson, 03/10/17

Paul Knoepfler, already well known for his prolific blogging at The Niche and for his role as a stem cell educator and tireless patient advocate – award winning no less – has taken on another project. Ask him a question about stem cells and you may get a live response. On February 26th, Dr. Knoepfler,…Read more

Right Turn: Stem cells in space

Author: Stacey Johnson, 11/13/15

Are you a wannabe astronaut? If you haven’t yet heard the news, NASA is hiring. Think you got the right stuff? The boys from One Direction do and you’ll know this if you have viewed their “NASA” video (over 185 million have clicked!).     Now, apart from enjoying a catchy tune and some eye…Read more

The waiting game: First human iPSC clinical trial on hold

Author: Guest, 09/01/15

. Nicole Forgione is a post-doctoral fellow working in the Fehlings group at the Toronto Western Research Institute. Currently she holds a Toronto Western Research Institute Fellowship to support her work on cell-based regenerative therapies for traumatic spinal cord injury. Nicole earned her BA from Wilfrid Laurier University, where she studied English Literature and Biology….Read more

Bad luck, bad science, or bad reporting?

Author: Sara M. Nolte, 01/19/15

. If you’ve been on the Internet at all in 2015, you’ve probably stumbled across headlines like “Two-thirds of cancers are due to ‘back luck,’ study finds” (CBSNews), “Most cancers are caused by bad luck not genes or lifestyle say scientists” (The Telegraph), “Cause of cancer revealed: majority of cases down to ‘bad luck’ rather…Read more

Right Turn: A not-so definitive RM holiday book list

Author: Stacey Johnson, 12/19/14

. Ah, the holidays. Fodder for journalists and bloggers alike. Last year, I brought you two themed blogs: an idea for a unique Christmas present – by the way, it’s on sale if you order now – and a list of movies and TV shows “about” regenerative medicine (RM) to watch when you have downtime….Read more

Right Turn: What do stem cells, ice and ALS have in common?

Author: Stacey Johnson, 08/22/14

. You have to be living under a rock – or perhaps spending every minute of your time culturing your cells – to be unaware of the ALS #Icebucketchallenge. Since it began on July 29 on social media, the American ALS Association has raised millions (nearly $42 million at the time of writing) in donations…Read more